GeekWire July 24, 2024
Taylor Soper

Oisín Biotechnologies, a Seattle-based startup focused on treating aging-related diseases, raised the first close of a $15 million Series A round.

  • The company is developing preclinical therapies to eliminate unwanted fat cells and build muscle mass to address frailty.
  • Oisín was founded in 2016...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article